GPR55 and metastatic neoplasm: The demonstration that GPR55 expression is increased in both types of EC, especially in the more aggressive Type 2 form, may also provide additional prognostic markers and therapeutic targets (Alhouayek et al. 2018) for individualised treatment and give hope for those women with metastatic disease.